SLIDE 1 Primary mitral valve regurgitation
Daniela Panayotova University Hospital St. Marina Varna, Bulgaria
SLIDE 2
Normal mitral valve structure
Normal mitral valves leaflets have four well-defined tissue layers, from the atrial to the ventricular aspect, these layers were the Auricularis, the Spongiosa, the Fibrosa, and the Ventricularis Each layer, containing characteristic cells and extracellular matrix, plays a different role
SLIDE 3 normal mitral valve
- the average valve leaflet thickness of clear zone is 0.7–0.9 mm
- percentage of the Spongiosa in relation to the valve thickness was
variable but almost 10%–20%
SLIDE 4 The main pathological hallmarks in degenerative mitral valve disease
- Abnormal accumulations of mucopolysaccharide in the spongiosa
- Infiltration to the Fibrosa as a structural core for valve tissue
- The layered architecture is destroyed
- Valve thickening and structural fragility are induced
- Individual collagen bundles are fragmented, coiled, disrupted
- Decreased consistency is derived from the complicated structure
- Similar changes are observed in chordal tendineae
SLIDE 5 The main pathological hallmarks in degenerative mitral valve disease
Immune activity against extracellular matrix proteins (such as fibrin and elastin18) and collagen I and III19)
- Rabkins, et al. hypothesized that activated metalloproteinase (MMP) and
cathepsins secretion by valvular interstitial cells (VICs) in mitral valves mediates extracellular matrix degeneration in cases with myxomatous degeneration
SLIDE 6 Pathohistological differences betw een FED and BML
Histologic sections of BML. Mucopolysaccharide were widely infiltrating into the Spongiosa, which thickened the valve in the BML group, giving the appearance of cystic spaces Histologic sections of FED. Valve tissue is usually thinner than in BML and its four-layer architecture of the leaflet tissue is almost preserved proportion of the Spongiosa is 30% proportion of the Spongiosa is over 50%
SLIDE 7
Carpentier Classification of mitral regurgitation
SLIDE 8 Two diferent mechnisms of regurgitation
Billowing – systolic protrusion of leaflet body above the annulus
- plane. Free edge remaining at or
below the annular plane during end-systole Prolapse – free edge of the leaflet above the plane of the annulus at end-systole, disruption of coaptation
Lang RM, Tsang W, Weinert L, Mor-Avi V, Chandra S. J Am Coll Cardiol 2011
SLIDE 9 Classification
Carpentier, et al. classified patients with degenerative mitral valve disease into two different forms on the basis of clinical patterns and gross appearance:
billowing mitral leaflet (BML) Barlow’s Disease fibroelastic deficiency (FED)
SLIDE 10 Degenerative mitral valve disease is divided into several subtypes according to clinical variability
Lang RM, Tsang W, Weinert L, Mor-Avi V, Chandra S. J Am Coll Cardiol 2011
SLIDE 11 Difference betw een Barlow ’s Disease and Fibroelastic Deficiency
Barlow’s Disease (BML)
- severely dilated annulus
- multiple segments of the leaflet(s)
showed billowing into the atrial side thickened with excess tissue
- prolapse has a wide and low shape
as a “plateau”
- thickened, elongated and fused
chordae with occasional calcification
- Calcification of papilary muscles
Fibroelastic Deficiency
- localized prolapse with healthy
adjacent segments
- area of prolapse is small
- the leaflet is typically flail with a high
prolapse height as a “tower”
- elongation of the chords is localized in
a few segments
- visible ruptured chords
- in most of cases only posterior
leaflet(P2) is involved
- the annulus is not dilated or is only
slightly dilated
SLIDE 12 Clinical characteristics of degenerative mitral valve disease
Barlow’s Disease (BML)
- patients are more likely to be
middle- aged, and they have a long-term evolution of mitral valve insufficiency (10–20 years) FED
- elderly patients, who did not have
a long history of a murmur
- disease duration tended to be
shorter and presented frequently with ruptured chordae
SLIDE 13 Special characteristics of BML
The posterior leaflet displaced toward the LA free wall away from the ventricular hinge → cul-de-sac along posterior annulus →anular fissures and calcification
SLIDE 14 Differentiation of Barlow ’s Disease From FED Using Prolapse Height, Volume
Chandra S, Lang RM et al., Circ Imaging 2011
SLIDE 15 Differentiation of Barlow ’s Disease From FED Using Prolapse Height, Volume, and PV-PH Ratio
FED ← 1.15ml ˃ PV ˃ 1.15ml → Barlow In some cases FED PV ˃ 1.15ml → PV-PH ratio, a novel parameter of prolapse, was able to differentiate Barlow’s disease from FED more precisely than crude prolapse volume or height PV-PH ratio Barlow ˃ 0.3 PV-PH ratio FED ˂ 0.3
SLIDE 16 Grading mitral regurgitation severity
Zoghbi WA, Enriquez-Sarano M, et al. J Am Soc Echocardiogr. 2003;16:777802.
SLIDE 17 Stages of primary mitral regurgitation
Nishimura et al 2014 AHA/ACC Valvular Heart Disease Guideline
SLIDE 18 Predictors of poor outcome in primary MR
Clinical characteristics Biologic markers Echo findings Advance age Elevated BNP Low EF ˂ 60% Symptoms of CHF EROA ˃ 40mm² Atrial fibrilation Left atrial index ≥ 60ml/m² Poor exercise capacity Pulmonary hypertemsion Abnormal LV strain
SLIDE 19 Outcome of Asymptomatic degenerative Mitral Regurgitation
Patients with a left atrial index 40 ml/m2 have lower 2-year survival and more cardiac events than those with mild or no left atrial enlargement. In this cohort, mitral surgery is associated with decreased mortality and cardiac events.
Julien Magne Heart 2012;98:584e591
SLIDE 20 Outcome of Asymptomatic degenerative Mitral Regurgitation
Maurice Enriquez-Sarano, M.D., N Engl J Med 2005;352:875-83.
456 patients (mean [±SD] age, 63±14 years; 63 percent men; ejection fraction, 70±8 percent) with asymptomatic organic mitral regurgitation, quantified according to current recommendations (regurgitant volume, 66±40 ml per beat; effective regurgitant orifice, 40±27 mm 2 ).
SLIDE 21 New biomarkers for primary mitral regurgitation
- High-density lipoprotein
- Apolipoprotein- A1
- Haptoglobin
- Haptoglobin-α2 chain
levels significantly decreased proportionally to the degree of mitral regurgitation when compared to controls
SLIDE 22 Indications for surgery for MR
Nishimura et al. JACC Vol. 63, No. 22, 2014 2014 AHA/ACC Valvular Heart Disease Guideline
SLIDE 23
Identify the prolapsing scallop( more then 3 segments)
SLIDE 24
Identify the prolapsing scallop (more then 3 segments)
SLIDE 25
Identify the prolapsing scallop (more then 3 segments)
SLIDE 26
Identify the prolapsing scallop( more then 3 segments+ruptured cords)
SLIDE 27
Identify the prolapsing scallop (A2)
SLIDE 28
Identify the prolapsing scallop (A2)
SLIDE 29
Identify the prolapsing scallop (P2)
SLIDE 30
Identify the prolapsing scallop (P2)
SLIDE 31
Identify the prolapsing scallop (P3)
SLIDE 32 Indicators for stress echocardiography in primary MR
- assessment of patients whose symptoms or LV dysfunction appear
disproportionate to the severity of MR at rest
- To define asymptomatic patients with severe MR with normal cavity
dimensions and good LV function
those who have a good prognosis who can avoid surgery those who are more likely to progress to symptoms and LV dysfunction who need surgery ear
SLIDE 33 Stress echocardiography for moderate MR
- 40mm² ˃ ERO ˃ 20mm²
- 60ml˃ RV ˃ 30ml
As a functional MR, degenerative MR can be dynamic with stress – induced changes One – forth of patients develop severe MR during stress
- ↑ ERO ≥ + 10 mm²
- ↑ RV ≥ + 15ml
Srtess Echo
Magne et al. JACC Vol. 56, No. 4, July 20, 2010:300–9
SLIDE 34 Changes in MR (RV)
RV ˃ 60ml 30ml ˂ RV ≤ 60ml
RV ˃ 60ml 30ml ˂ RV ≤ 60ml RV ≤ 30 ml
SLIDE 35 Changes in MR (ERO)
ERO ˃ 40 mm²
20mm² ˂ ERO ≤ 40mm² ERO ˃ 40mm² 20mm² ˂ ERO ≤ 40mm² ERO ≤ 20 mm²
SLIDE 36 Why does primary MR worsen during exercise?
- changes in LV and annular geometry
- papillary muscle traction, resulting in the fibrosis
SLIDE 37 Stress echocardiography -
correct identification of surgical candidates
EROA ↑ ˃ 10mm² RV ↑ ˃ 15ml Peak TR maximal velocity and calculation for PASP PASP ˃ 60mmHg Peak LVEF LVEF fail to improve by ≥4% Global longitudinal strain GLS fail to improve by ≥ 1.9% e BNP ↑ ≥ 90 pg/ml ( at rest ˃40 pg/ml)
SLIDE 38 Simptom-free survival
Magne et al. JACC Vol. 56, No. 4, 2010
Symptom-free survival of patients with marked exercise-induced increase in RV (≥ +15 ml) compared with those with marked decrease (˃ -15 ml) or no marked change (˂ +15 ml and ˃ -15 ml).
SLIDE 39 Prognostic importance of left ventricular longitudinal function in asymptomatic degenerative mitral regurgitation
Julien Magne Heart 2012;98:584e591
SLIDE 40 Prognostic importance of left ventricular longitudinal function in asymptomatic degenerative mitral regurgitation
reduction in GLS from rest reduction in GLS to exercise
SLIDE 41 Impact of a left Ventricular ejection index in asymptomatic primary MR
LV ejection index (LVEI) = Indexed LV end−systolic diameter LVOT TVI LVEI ˃ 1.13
- an independent predictor of postoperative LV dissfunction
- a powerful determinant of postoperative cardiovascular mortality
SLIDE 42 Impact of a left Ventricular ejection index in asymptomatic primary MR
LVOT TVI – 17,4 cm BSA – 1.75 m² Indexed LVESD – 14.9/m² LVEI – 0.84
SLIDE 43 The echocardiography – prediction of complexity of MV repair
- Multisegment involvement
- Anterior leaflet prolapse
- Scarcity of leaflet tissue
- Severe calcification
- Prolapsing height
- Annular dilatation ˃ 50mm
SLIDE 44
After MV repair
SLIDE 45